Keyphrases
Cardiogenic Shock
100%
Left Ventricular Assist Device
100%
Early Outcome
100%
Impella 5.5
100%
Temporary Leave
100%
Overall Survival
33%
Cardiomyopathy
33%
Acute Myocardial Infarction
33%
Procedural Characteristics
33%
High Risk
16%
Day Range
16%
Ablation
16%
FDA-approved Drugs
16%
Subgroup Analysis
16%
Survival Outcomes
16%
Revascularization
16%
Coronary Artery Bypass Grafting
16%
Electrophysiology
16%
Baseline Characteristics
16%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
16%
Clinical Experience
16%
Impella
16%
Conventional Strategy
16%
Procedural Outcomes
16%
Quality Database
16%
Duration of Support
16%
Forward Flow
16%
Myocarditis
16%
Nursing and Health Professions
Left Ventricular Assist Device
100%
Cardiogenic Shock
100%
Explant
50%
Overall Survival
33%
Acute Heart Infarction
33%
Myocardial Disease
33%
Coronary Artery Bypass Graft
16%
Food and Drug Administration
16%
Extracorporeal Oxygenation
16%
Revascularization
16%
Myocarditis
16%
Medicine and Dentistry
Cardiogenic Shock
100%
Left Ventricular Assist Device
100%
Overall Survival
33%
Acute Heart Infarction
33%
Myocardial Disease
33%
Electrophysiology
16%
Prospective Study
16%
Subgroup Analysis
16%
Revascularization
16%
Coronary Artery Bypass Graft
16%
Extracorporeal Membrane Oxygenation
16%
Myocarditis
16%
Biochemistry, Genetics and Molecular Biology
Explant
100%
Overall Survival
66%
Electrophysiology
33%
Prospective Study
33%
Extracorporeal Oxygenation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiogenic Shock
100%
Overall Survival
33%
Acute Heart Infarction
33%
Myocardial Disease
33%
Prospective Study
16%
Myocarditis
16%